Cengild Medical Berhad (KLSE:CENGILD)
Malaysia · Delayed Price · Currency is MYR 0.2050
-0.0100 (-4.65%)
At close: Jun 5, 2026
Cengild Medical Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 171 | 192 | 262 | 329 | 328 | - | |
Market Cap Growth | -16.33% | -26.98% | -20.25% | 0.45% | - | - |
Enterprise Value | 202 | 138 | 188 | 255 | 331 | - |
Last Close Price | 0.20 | 0.22 | 0.30 | 0.36 | 0.36 | - |
PE Ratio | 16.66 | 17.33 | 23.68 | 24.76 | 34.88 | - |
Forward PE | - | 23.00 | 23.00 | 23.00 | 24.24 | - |
PS Ratio | 2.33 | 2.40 | 3.93 | 4.68 | 5.08 | - |
PB Ratio | 1.47 | 1.67 | 2.36 | 3.10 | 3.52 | - |
P/TBV Ratio | 1.47 | 1.67 | 2.36 | 3.10 | 3.52 | - |
P/FCF Ratio | - | - | - | 27.92 | 21.98 | - |
P/OCF Ratio | 18.74 | 11.91 | 20.28 | 23.65 | 21.37 | - |
PEG Ratio | - | 0.64 | 0.64 | 0.64 | 0.67 | - |
EV/Sales Ratio | 2.76 | 1.72 | 2.82 | 3.62 | 5.14 | - |
EV/EBITDA Ratio | 12.48 | 7.10 | 11.94 | 15.59 | 22.72 | - |
EV/EBIT Ratio | 19.68 | 9.60 | 14.24 | 17.60 | 28.61 | - |
EV/FCF Ratio | -3.23 | - | - | 21.60 | 22.21 | - |
Debt / Equity Ratio | 0.75 | 0.42 | 0.07 | 0.14 | 0.17 | 1.76 |
Debt / EBITDA Ratio | 5.66 | 2.28 | 0.47 | 0.85 | 1.01 | 1.25 |
Debt / FCF Ratio | - | - | - | 1.27 | 1.09 | 1.92 |
Net Debt / Equity Ratio | 0.27 | -0.33 | -0.74 | -0.79 | -0.76 | 1.25 |
Net Debt / EBITDA Ratio | 2.18 | -1.94 | -5.22 | -5.15 | -4.87 | 0.98 |
Net Debt / FCF Ratio | -0.50 | 1.78 | 29.40 | -7.14 | -4.76 | 1.36 |
Asset Turnover | 0.38 | 0.51 | 0.51 | 0.56 | 0.78 | 1.36 |
Inventory Turnover | 17.79 | 22.93 | 23.09 | 31.23 | 36.62 | 42.83 |
Quick Ratio | 3.81 | 4.78 | 6.59 | 9.17 | 7.91 | 1.06 |
Current Ratio | 3.93 | 4.91 | 6.73 | 9.32 | 8.04 | 1.16 |
Return on Equity (ROE) | 8.99% | 12.02% | 11.01% | 13.35% | 17.60% | 84.90% |
Return on Assets (ROA) | 3.01% | 5.72% | 6.25% | 7.19% | 8.74% | 19.43% |
Return on Invested Capital (ROIC) | 5.03% | 20.41% | 37.02% | 50.17% | 33.82% | 33.92% |
Return on Capital Employed (ROCE) | 4.70% | 8.90% | 11.20% | 12.00% | 10.70% | 41.30% |
Earnings Yield | 5.51% | 5.77% | 4.22% | 4.04% | 2.87% | - |
FCF Yield | -36.58% | -11.06% | -1.07% | 3.58% | 4.55% | - |
Dividend Yield | 4.73% | 4.35% | 2.51% | 2.04% | 1.03% | - |
Payout Ratio | 61.96% | 73.07% | 55.64% | 45.60% | - | 72.81% |
Buyback Yield / Dilution | 0.02% | 0.11% | -1.00% | -27.94% | -7.56% | -4700.00% |
Total Shareholder Return | 4.75% | 4.46% | 1.51% | -25.90% | -6.53% | -4700.00% |